MCE CARREL is particularly active across the biotech industry, often assisting with investment and commercialisation issues. Alexandra Carrel is noted for her vast knowledge of mandates concerning the manufacturing, production, and distribution of healthcare products, and the negotiation of licence and collaboration agreements. Drawing on her prior expertise within the pharma industry, Mathilde Salavin often advises on clinical trial agreements and commercial partnerships.
Legal 500 Editorial commentary
Accolades
Client satisfaction: Lawyer & team quality
Client satisfaction: Billing & efficiency
Client satisfaction: Sector knowledge
Testimonials
Collated independently by Legal 500 research team.
‘Very good listening skills and good understanding of our needs, availability and responsiveness of the team, pragmatic and wise advice in the face of our problems.’
‘Alexandra Carrel is a high-quality partner, and a very good, wise and strategic advisor who knows how to stay on top of her files.’
Key clients
- Imcheck
- Egle Therapeutics
Work highlights
Advised Vect-Horus on the negotiation of an exclusive licence agreement with Novo Nordisk to develop targeted therapeutics.
Practice head
Alexandra Carrel; Mathilde Salavin
Other key lawyers
Cédric Hascoet; Antoine Robin